Neurocrine Biosciences Inc Q3 Profit Increases, Beats Estimates

(RTTNews) - Neurocrine Biosciences Inc (NBIX) reported a profit for its third quarter that increased from the same period last year and beat the Street estimates.

The company's earnings totaled $129.8 million, or $1.24 per share. This compares with $83.1 million, or $0.82 per share, in last year's third quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $189.2 million or $1.81 per share for the period.

Analysts on average had expected the company to earn $1.50 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 24.7% to $622.1 million from $498.8 million last year.

Neurocrine Biosciences Inc earnings at a glance (GAAP) :

-Earnings (Q3): $129.8 Mln. vs. $83.1 Mln. last year. -EPS (Q3): $1.24 vs. $0.82 last year. -Revenue (Q3): $622.1 Mln vs. $498.8 Mln last year.